Skip to content

Therapeutic effect of extracorporeal shockwave therapy for meniscal degenerative tear

Clinical study on therapeutic effect of extracorporeal shockwave therapy for meniscal degenerative tear

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032200082
Enrollment
30
Registered
2020-09-01
Start date
2020-09-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniscal degenerative tear

Interventions

Extracorporeal shockwave therapy

Sponsors

Chikuda Hirotaka
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients over 40 years old 2) Patients diagnosed with meniscal degeneration by MRI 3) Patients with knee pain above NRS2 4) Patients with PS between 0 and 1 5) Outpatient 6) Patients obtained from consent documents

Exclusion criteria

Exclusion criteria: 1) Patients with knee osteoarthritis of G3 or higher according to the Kellgren-Lawrence classification 2) Patients diagnosed with cognitive decline at the physician's discretion 3) Patients with untreated blood coagulation disorders such as hemophilia or patients taking anticoagulants 4) Patients with thrombosis 5) Patients with malignant tumor 6) Pregnant woman 7) Patients who have received steroid treatment for 6 months or more, or within 6 weeks after steroid injection 8) Patients judged inappropriate by the doctor

Design outcomes

Primary

MeasureTime frame
T2 value in MRI

Secondary

MeasureTime frame
Patient background (Age, Sex, Height, Weight, Body mass index, Medical history, Comorbidities, Drinking history, Smoking history) ESWT conditins (Energy flow density, Freaquency, Total energy) NRS (Walking, going up and down stairs) Clinical score (KOOS, IKDC score, Lysholme score) Scientific findings (Ballottement of patella, Range of motion, Mcmurray test, Watson-Jones test, Lachman test, Posterior drawer test) Adverse event Daily use of oral analgesics Transition rate to surgery after starting treatment

Contacts

Public ContactShogo Hashimoto

Department of Orthopaedic Surgery, Gunma University Graduate School of Medicine

m1620023@gunma-u.ac.jp+81-27-220-8269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026